Surgeons work to remove mesothelioma when it's diagnosed at an early stage. In some cases this may cure the cancer. Most of the time, it isn't possible to remove all of the cancer. In this situation, surgery may help to reduce the signs and symptoms caused by mesothelioma spreading in your body.

ADI-PEG20 or pegargiminase is being hailed as the first drug of its kind to be incorporated successfully with chemotherapy in 20 years. Researchers say this new drug could bring hope to thousands of mesothelioma survivors and their families. The drug blocks the cancer's food supply, ensuring the disease can't spread.

In 2020, combination immunotherapy with ipilimumab and nivolumab was approved as first-line systemic therapy for mesothelioma following release of the results from the CheckMate 743 trial.

Mesothelioma Survival Rate: The mesothelioma survival rates is typically 4 to 18 months after diagnosis, but there have been patients diagnosed with mesothelioma who have lived longer than 10 years. The current five-year survival rate for the disease is just 10 percent.